Products - Diabetes | Topic | NICE

Showing 15 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

3C Patch for treating diabetic foot ulcers (MTG66)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
7 March 2022
Diabetes (type 1 and type 2) in children and young people: diagnosis and management – periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Type 1 diabetes in adults: diagnosis and management – periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Type 2 diabetes in adults: management - periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
6 June 2022
Expected publication date:
14 September 2022
Dexamethasone intravitreal implant for treating diabetic macular oedema in people without a pseudophakic lens [ID3951]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
14 September 2022
Brolucizumab for treating diabetic macular oedema [ID3902]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
16 November 2022
Diabetic foot problems: prevention and management (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
18 January 2023
Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
3 January 2024
Diabetic retinopathy
Status:
In development
Programme:
NICE guideline
Expected publication date:
3 April 2024
Faricimab for treating diabetic macular oedema [ID3899]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for treating type 2 diabetes ID3938
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition TS ID 10753
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Type 2 diabetes in adults: management (medicines update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC